Company history:

In 2006 it was 400 years ago that Rembrandt van Rijn was born in Leiden. Currently this town is host to a new generation of “Dutch masters”.

Dedicated to the application of biocatalysis ChiralVision was founded in 2006, privately funded with headquarters in Leiden, The Netherlands

Some "historic" highlights:

2006 - Introduction of first Immozymes and chiral products

2006 - 1st patented custom API process

2007 - Collaboration with Genencor International

2008 - Products available via Sigma-Aldrich

2008 - 1st Immozyme in API production process

2009 - Over 100 immobilized enzyme products

2010 - Over 60 unique chiral compounds in portfolio

2010 - Food & Nutrition Delta funding for "healthy fats"

2012 - EU funding for clean water research (Endetech)

2013 - EU project for phosphate recycling (Phosfarm)

2015 - Collaboration with Nordic Chemquest (now SpinChem) for SpinChem reactor development

see the news page for recent developments

Business model:

ChiralVision develops biocatalysis based technologies and solutions. We can help you to develop new and proprietary solutions in various markets, or take your existing technology and develop a scalable process.

We are a supplier of off-shelf (immobilized) enzymes, chiral molecules, custom products, technology subcontractor or collaborator in a joint development effort.

To discuss your interest please email or phone us:


Tel: +31 71 332 2124


"Removal of Endocrine Disrupting Chemicals in Wastewater by Enzymatic Treatment with Fungal Laccases"; Becker et al; Org. Process Res. Dev., 2017, 21 (4), pp 480–491

"Removal of antibiotics in wastewater by enzymatic treatment with fungal laccase - Degradation of compounds does not always eliminate toxicity." Becker et al; Bioresour Technol 2016 Nov 4;219:500-509. Epub 2016 Aug 4.

"Cleaning Up Drugs In Wastewater", August 3, 2015 Issue - Vol. 93 Issue 31 _ Chemical & Engineering News

"Free acids and immobilised enzymes".Specialty Chemicals Magazine, September 2013, p 28.

"Macroporous beads for enzyme immobilization with high activity retention"

Pharmachem, September/October 2010, p 11.

"Immobilized Bulk Enzymes Catalysts for Chiral Intermediate and Chiral API Production"

CHEManager Europe, June 2009, page 9.

"Immobilized bulk proteases in enzymatic resolution. Production of non-natural amino acids with high chiral purity"

Pharmachem, April/May 2009, p 10.

"Carrier-bound enzymes for chiral compound production".SP2, April 2007, p 26.

"Industrial biocatalysis with standard hydrolytic bulk enzymes". Specialty Chemicals Magazine, October 2007, Vol 27, nr 8, p 38.